Cargando…
Atovaquone exerts its anticancer effect by inhibiting Na(+)/K(+)-ATPase ion transport in canine cancer cells
BACKGROUND AND AIM: New anticancer drugs are being developed to avoid the toxicity and chemoresistance of the currently available drugs. The Food and Drug Administration-approved anti-malarial drug atovaquone is known to act as a selective oxidative phosphorylation inhibitor in the mitochondria by c...
Autor principal: | Alharbi, Yousef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Veterinary World
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421541/ https://www.ncbi.nlm.nih.gov/pubmed/37577204 http://dx.doi.org/10.14202/vetworld.2023.1185-1192 |
Ejemplares similares
-
Oxidative stress induced by the anti-cancer agents, plumbagin, and atovaquone, inhibits ion transport through Na(+)/K(+)-ATPase
por: Alharbi, Yousef, et al.
Publicado: (2020) -
Plumbagin-induced oxidative stress leads to inhibition of Na(+)/K(+)-ATPase (NKA) in canine cancer cells
por: Alharbi, Yousef, et al.
Publicado: (2019) -
Mechanism of potassium ion uptake by the
Na(+)/K(+)-ATPase
por: Castillo, Juan P., et al.
Publicado: (2015) -
Ultrastructure of Na,K-transport vesicles reconstituted with purified renal Na,K-ATPase
Publicado: (1980) -
Activation of Piezo1 Increases Na,K-ATPase-Mediated Ion Transport in Mouse Lens
por: Shahidullah, Mohammad, et al.
Publicado: (2022)